Global Dermal Fillers and Botulinum Toxin Market Research Report 2023(Status and Outlook)


Attention: There is an updated edition available for this report.

Global Dermal Fillers and Botulinum Toxin Market Research Report 2023(Status and Outlook)



Report Overview

Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism.

Market competition is intense. Allergan, Galderma, LG Life Science, Ipsen, Merz, etc. are the leaders of the industry. Allergan hold the largest market share of 58.7% in 2019.

The Global Dermal Fillers and Botulinum Toxin Market Size was estimated at USD 10550.00 million in 2022 and is projected to reach USD 26724.84 million by 2029, exhibiting a CAGR of 0.14 during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Dermal Fillers and Botulinum Toxin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Dermal Fillers and Botulinum Toxin Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Dermal Fillers and Botulinum Toxin market in any manner.

Global Dermal Fillers and Botulinum Toxin Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Allergan

Galderma

LG Life Science

Merz

Medytox

Bloomage

Bohus BioTech

Sinclair Pharma

IMEIK

Suneva Medical

Teoxane

Luminera

SciVision Biotech

Haohai Bio

Ipsen

LIBP

US World Meds

Hugel

Daewoong

Market Segmentation (by Type)

Dermal Fillers

Botulinum Toxin

Market Segmentation (by Application)

Passenger cars

Commercial vehicles

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Dermal Fillers and Botulinum Toxin Market

Overview of the regional outlook of the Dermal Fillers and Botulinum Toxin Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Dermal Fillers and Botulinum Toxin Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Dermal Fillers and Botulinum Toxin
1.2 Key Market Segments
1.2.1 Dermal Fillers and Botulinum Toxin Segment by Type
1.2.2 Dermal Fillers and Botulinum Toxin Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Dermal Fillers and Botulinum Toxin Market Overview
2.1 Global Market Overview
2.1.1 Global Dermal Fillers and Botulinum Toxin Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Dermal Fillers and Botulinum Toxin Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Dermal Fillers and Botulinum Toxin Market Competitive Landscape
3.1 Global Dermal Fillers and Botulinum Toxin Sales by Manufacturers (2018-2023)
3.2 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Manufacturers (2018-2023)
3.3 Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Dermal Fillers and Botulinum Toxin Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Dermal Fillers and Botulinum Toxin Sales Sites, Area Served, Product Type
3.6 Dermal Fillers and Botulinum Toxin Market Competitive Situation and Trends
3.6.1 Dermal Fillers and Botulinum Toxin Market Concentration Rate
3.6.2 Global 5 and 10 Largest Dermal Fillers and Botulinum Toxin Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Dermal Fillers and Botulinum Toxin Industry Chain Analysis
4.1 Dermal Fillers and Botulinum Toxin Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Dermal Fillers and Botulinum Toxin Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Dermal Fillers and Botulinum Toxin Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2018-2023)
6.3 Global Dermal Fillers and Botulinum Toxin Market Size Market Share by Type (2018-2023)
6.4 Global Dermal Fillers and Botulinum Toxin Price by Type (2018-2023)
7 Dermal Fillers and Botulinum Toxin Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Dermal Fillers and Botulinum Toxin Market Sales by Application (2018-2023)
7.3 Global Dermal Fillers and Botulinum Toxin Market Size (M USD) by Application (2018-2023)
7.4 Global Dermal Fillers and Botulinum Toxin Sales Growth Rate by Application (2018-2023)
8 Dermal Fillers and Botulinum Toxin Market Segmentation by Region
8.1 Global Dermal Fillers and Botulinum Toxin Sales by Region
8.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Region
8.1.2 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region
8.2 North America
8.2.1 North America Dermal Fillers and Botulinum Toxin Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Dermal Fillers and Botulinum Toxin Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Dermal Fillers and Botulinum Toxin Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Dermal Fillers and Botulinum Toxin Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Allergan
9.1.1 Allergan Dermal Fillers and Botulinum Toxin Basic Information
9.1.2 Allergan Dermal Fillers and Botulinum Toxin Product Overview
9.1.3 Allergan Dermal Fillers and Botulinum Toxin Product Market Performance
9.1.4 Allergan Business Overview
9.1.5 Allergan Dermal Fillers and Botulinum Toxin SWOT Analysis
9.1.6 Allergan Recent Developments
9.2 Galderma
9.2.1 Galderma Dermal Fillers and Botulinum Toxin Basic Information
9.2.2 Galderma Dermal Fillers and Botulinum Toxin Product Overview
9.2.3 Galderma Dermal Fillers and Botulinum Toxin Product Market Performance
9.2.4 Galderma Business Overview
9.2.5 Galderma Dermal Fillers and Botulinum Toxin SWOT Analysis
9.2.6 Galderma Recent Developments
9.3 LG Life Science
9.3.1 LG Life Science Dermal Fillers and Botulinum Toxin Basic Information
9.3.2 LG Life Science Dermal Fillers and Botulinum Toxin Product Overview
9.3.3 LG Life Science Dermal Fillers and Botulinum Toxin Product Market Performance
9.3.4 LG Life Science Business Overview
9.3.5 LG Life Science Dermal Fillers and Botulinum Toxin SWOT Analysis
9.3.6 LG Life Science Recent Developments
9.4 Merz
9.4.1 Merz Dermal Fillers and Botulinum Toxin Basic Information
9.4.2 Merz Dermal Fillers and Botulinum Toxin Product Overview
9.4.3 Merz Dermal Fillers and Botulinum Toxin Product Market Performance
9.4.4 Merz Business Overview
9.4.5 Merz Dermal Fillers and Botulinum Toxin SWOT Analysis
9.4.6 Merz Recent Developments
9.5 Medytox
9.5.1 Medytox Dermal Fillers and Botulinum Toxin Basic Information
9.5.2 Medytox Dermal Fillers and Botulinum Toxin Product Overview
9.5.3 Medytox Dermal Fillers and Botulinum Toxin Product Market Performance
9.5.4 Medytox Business Overview
9.5.5 Medytox Dermal Fillers and Botulinum Toxin SWOT Analysis
9.5.6 Medytox Recent Developments
9.6 Bloomage
9.6.1 Bloomage Dermal Fillers and Botulinum Toxin Basic Information
9.6.2 Bloomage Dermal Fillers and Botulinum Toxin Product Overview
9.6.3 Bloomage Dermal Fillers and Botulinum Toxin Product Market Performance
9.6.4 Bloomage Business Overview
9.6.5 Bloomage Recent Developments
9.7 Bohus BioTech
9.7.1 Bohus BioTech Dermal Fillers and Botulinum Toxin Basic Information
9.7.2 Bohus BioTech Dermal Fillers and Botulinum Toxin Product Overview
9.7.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Product Market Performance
9.7.4 Bohus BioTech Business Overview
9.7.5 Bohus BioTech Recent Developments
9.8 Sinclair Pharma
9.8.1 Sinclair Pharma Dermal Fillers and Botulinum Toxin Basic Information
9.8.2 Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Overview
9.8.3 Sinclair Pharma Dermal Fillers and Botulinum Toxin Product Market Performance
9.8.4 Sinclair Pharma Business Overview
9.8.5 Sinclair Pharma Recent Developments
9.9 IMEIK
9.9.1 IMEIK Dermal Fillers and Botulinum Toxin Basic Information
9.9.2 IMEIK Dermal Fillers and Botulinum Toxin Product Overview
9.9.3 IMEIK Dermal Fillers and Botulinum Toxin Product Market Performance
9.9.4 IMEIK Business Overview
9.9.5 IMEIK Recent Developments
9.10 Suneva Medical
9.10.1 Suneva Medical Dermal Fillers and Botulinum Toxin Basic Information
9.10.2 Suneva Medical Dermal Fillers and Botulinum Toxin Product Overview
9.10.3 Suneva Medical Dermal Fillers and Botulinum Toxin Product Market Performance
9.10.4 Suneva Medical Business Overview
9.10.5 Suneva Medical Recent Developments
9.11 Teoxane
9.11.1 Teoxane Dermal Fillers and Botulinum Toxin Basic Information
9.11.2 Teoxane Dermal Fillers and Botulinum Toxin Product Overview
9.11.3 Teoxane Dermal Fillers and Botulinum Toxin Product Market Performance
9.11.4 Teoxane Business Overview
9.11.5 Teoxane Recent Developments
9.12 Luminera
9.12.1 Luminera Dermal Fillers and Botulinum Toxin Basic Information
9.12.2 Luminera Dermal Fillers and Botulinum Toxin Product Overview
9.12.3 Luminera Dermal Fillers and Botulinum Toxin Product Market Performance
9.12.4 Luminera Business Overview
9.12.5 Luminera Recent Developments
9.13 SciVision Biotech
9.13.1 SciVision Biotech Dermal Fillers and Botulinum Toxin Basic Information
9.13.2 SciVision Biotech Dermal Fillers and Botulinum Toxin Product Overview
9.13.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Product Market Performance
9.13.4 SciVision Biotech Business Overview
9.13.5 SciVision Biotech Recent Developments
9.14 Haohai Bio
9.14.1 Haohai Bio Dermal Fillers and Botulinum Toxin Basic Information
9.14.2 Haohai Bio Dermal Fillers and Botulinum Toxin Product Overview
9.14.3 Haohai Bio Dermal Fillers and Botulinum Toxin Product Market Performance
9.14.4 Haohai Bio Business Overview
9.14.5 Haohai Bio Recent Developments
9.15 Ipsen
9.15.1 Ipsen Dermal Fillers and Botulinum Toxin Basic Information
9.15.2 Ipsen Dermal Fillers and Botulinum Toxin Product Overview
9.15.3 Ipsen Dermal Fillers and Botulinum Toxin Product Market Performance
9.15.4 Ipsen Business Overview
9.15.5 Ipsen Recent Developments
9.16 LIBP
9.16.1 LIBP Dermal Fillers and Botulinum Toxin Basic Information
9.16.2 LIBP Dermal Fillers and Botulinum Toxin Product Overview
9.16.3 LIBP Dermal Fillers and Botulinum Toxin Product Market Performance
9.16.4 LIBP Business Overview
9.16.5 LIBP Recent Developments
9.17 US World Meds
9.17.1 US World Meds Dermal Fillers and Botulinum Toxin Basic Information
9.17.2 US World Meds Dermal Fillers and Botulinum Toxin Product Overview
9.17.3 US World Meds Dermal Fillers and Botulinum Toxin Product Market Performance
9.17.4 US World Meds Business Overview
9.17.5 US World Meds Recent Developments
9.18 Hugel
9.18.1 Hugel Dermal Fillers and Botulinum Toxin Basic Information
9.18.2 Hugel Dermal Fillers and Botulinum Toxin Product Overview
9.18.3 Hugel Dermal Fillers and Botulinum Toxin Product Market Performance
9.18.4 Hugel Business Overview
9.18.5 Hugel Recent Developments
9.19 Daewoong
9.19.1 Daewoong Dermal Fillers and Botulinum Toxin Basic Information
9.19.2 Daewoong Dermal Fillers and Botulinum Toxin Product Overview
9.19.3 Daewoong Dermal Fillers and Botulinum Toxin Product Market Performance
9.19.4 Daewoong Business Overview
9.19.5 Daewoong Recent Developments
10 Dermal Fillers and Botulinum Toxin Market Forecast by Region
10.1 Global Dermal Fillers and Botulinum Toxin Market Size Forecast
10.2 Global Dermal Fillers and Botulinum Toxin Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Dermal Fillers and Botulinum Toxin Market Size Forecast by Country
10.2.3 Asia Pacific Dermal Fillers and Botulinum Toxin Market Size Forecast by Region
10.2.4 South America Dermal Fillers and Botulinum Toxin Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Dermal Fillers and Botulinum Toxin by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Dermal Fillers and Botulinum Toxin Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Dermal Fillers and Botulinum Toxin by Type (2024-2029)
11.1.2 Global Dermal Fillers and Botulinum Toxin Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Dermal Fillers and Botulinum Toxin by Type (2024-2029)
11.2 Global Dermal Fillers and Botulinum Toxin Market Forecast by Application (2024-2029)
11.2.1 Global Dermal Fillers and Botulinum Toxin Sales (K Units) Forecast by Application
11.2.2 Global Dermal Fillers and Botulinum Toxin Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings